Oral Antivirals for Pandemic Preparedness

Millions of lives are being lost to viral diseases each year, and there is a continuing need for new and better antiviral therapies. 

Clear Creek Bio’s mission is to develop therapies that meet the global need for safe, effective, and easy-to-administer antivirals.

About 

Clear Creek Bio

Clear Creek Bio is a clinical-stage biotech developing oral antivirals for pandemic preparedness. We are focused on host-targeting and direct-acting small molecule antiviral therapeutics targeting SARS-CoV-2 and other medically important viruses.

Pipeline

Inspired by Science

Translating new insights in viral mechanisms, targeting both host and viral pathways.

Our Team

Passionate and Experienced

The Clear Creek Bio team has diverse pharmaceutical leadership experience, successfully driving antiviral discovery, development, and clinical trials. Our team has successfully advanced programs across multiple therapeutic indications resulting in more than 20 NDA approvals including 10 in antivirals.

585 Massachusetts Avenue
Cambridge, MA 02139
info@clearcreekbio.com

© Clear Creek Bio, 2021  |  Privacy Policy  |  Terms  |  Design by Ape to Zebra